- Trials with a EudraCT protocol (1,232)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
1,232 result(s) found for: Y STR.
Displaying page 1 of 62.
EudraCT Number: 2015-000313-40 | Sponsor Protocol Number: GS-US-236-0112 | Start Date*: 2015-01-29 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1... | |||||||||||||
Medical condition: Human Immunodeficiency Virus, Type 1 (HIV-1) Infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002780-26 | Sponsor Protocol Number: GS-US-292-0106 | Start Date*: 2015-01-27 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in H... | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV-1) Infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001341-41 | Sponsor Protocol Number: EKTKet01 | Start Date*: 2012-11-13 |
Sponsor Name:Universitätsklinik für Psychiatrie und Psychotherapie I | ||
Full Title: Propofol vs. Ketamin | ||
Medical condition: major depression, bipolar disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005628-16 | Sponsor Protocol Number: Uni-Koeln-1473 | Start Date*: 2012-08-06 |
Sponsor Name:University of Cologne | ||
Full Title: FTO-genotype dependent weight reduction under treatment with bromocriptin in obese patients | ||
Medical condition: Obesity with BMI ≥ 30kg/m² | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003061-25 | Sponsor Protocol Number: MPEEG_2 | Start Date*: 2016-12-14 |
Sponsor Name:Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg | ||
Full Title: Pharmaco-EEG for Montelukast. Can we detect neural changes during medication with Montelukast in the EEG? | ||
Medical condition: Montelukast is indicated for prophylaxis and chronic treatment of asthma and for the relief of symptoms of seasonal allergic rhinitis. We investigate side effects of Montelukast, specifically poten... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000125-36 | Sponsor Protocol Number: Dapto | Start Date*: 2016-08-02 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: Daptomycin concentration in drainage fluid and blood samples of ICU patients | ||
Medical condition: Intensive Care Patients after Surgery treated with Daptomycin and wound draingae | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000749-21 | Sponsor Protocol Number: 4.20 | Start Date*: 2016-03-14 |
Sponsor Name:Medizinische Hochschule Hannover | ||
Full Title: Botulinumtoxin A for emotional stabilization in borderline personality disorder | ||
Medical condition: Borderline personality disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000578-31 | Sponsor Protocol Number: Rostock-Benralizumab-2018-1 | Start Date*: 2018-07-05 |
Sponsor Name:University Medicine Rostock | ||
Full Title: Impact of benralizumab treatment on circulating dendritic cells in patients with eosinophilic asthma | ||
Medical condition: Eosinophilic Asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002830-19 | Sponsor Protocol Number: GS-US-292-0117 | Start Date*: 2013-11-27 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Two-Part Study to Evaluate the Efficacy of Tenofovir Alafenamide versus Placebo Added to a Failing Regimen Followed by Treatment with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alaf... | |||||||||||||
Medical condition: HIV-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003056-21 | Sponsor Protocol Number: ReCaLL-2013 | Start Date*: 2014-03-19 | |||||||||||
Sponsor Name:GWT-TUD GmbH | |||||||||||||
Full Title: Evaluation of an additional therapeutic approach to diabetic macular edema by combining standard therapy (intravitreal injection of a VEGF‐inhibitor) with micropulse diode laser treatment in a rand... | |||||||||||||
Medical condition: visual impairment due to diabetic macular edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003223-30 | Sponsor Protocol Number: HeMiLa | Start Date*: 2017-08-14 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: Prophylactic treatment of hemiplegic migraine with Lamotrigine | ||
Medical condition: Familiar hemplegic migraine | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-000978-35 | Sponsor Protocol Number: STOP-SPG5 | Start Date*: 2015-10-21 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: Statin Treatment of Oxysterol Pathology in SPG5: a Randomized Controlled Trial -Proof of Principle | ||
Medical condition: SPG5 | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006776-11 | Sponsor Protocol Number: 07ct/am06perm | Start Date*: 2008-02-20 |
Sponsor Name:gepepharm GmbH | ||
Full Title: Investigation of the local tolerability of pedimitex Lösung 0.5% - a permethrin containing solution - in 100 patients with head lice infection of both gender | ||
Medical condition: The product is intended to be used by patients suffering from head lice infestation. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003151-62 | Sponsor Protocol Number: BENOS | Start Date*: 2014-10-09 |
Sponsor Name:Infectopharm Arzneimittel und Consilium GmbH | ||
Full Title: A randomised, two-period two-stage cross-over study on the relative bioavailability of two different formulations of single doses of noscapine (phase I/IV, open-label) in healthy volunteers (fasted... | ||
Medical condition: healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002012-12 | Sponsor Protocol Number: BENOS-2-L | Start Date*: 2021-12-13 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: A randomised, two-period two-stage cross-over study on the relative bioavailability of two different liquid formulations of single noscapine doses (phase I/IV, open-label) in healthy volunteers (fa... | ||
Medical condition: Healthy controls | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001431-27 | Sponsor Protocol Number: CovidVal01 | Start Date*: 2020-06-05 |
Sponsor Name:Klinikum St. Georg gGmbH | ||
Full Title: Treatment of Sars-CoV2 infections (Covid-19) in patients without or with chronic kidney disease (CKD) with valsartan vs placebo, a three-armed randomized, partly blinded trial | ||
Medical condition: Sars-Cov2 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003179-12 | Sponsor Protocol Number: MN0511_1 | Start Date*: 2012-01-09 |
Sponsor Name:University Hospital of Wuerzburg, Medical Director | ||
Full Title: Mineralocorticoid Receptor antagonists in End stage reNal DiseAse | ||
Medical condition: Hemodialysis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002445-15 | Sponsor Protocol Number: Prevent-COVID | Start Date*: 2021-09-27 |
Sponsor Name:InfectoPharm Arzneimittel und Consilium GmbH | ||
Full Title: Placebo-kontrollierte randomisierte doppel-blinde Phase III Studie zur Wirksamkeit und Sicherheit von Ivermectin Tabletten (Driponin®) für die Prophylaxe der COVID-19 Erkrankung bei im Haushalt leb... | ||
Medical condition: COVID-19 Post-Expositionsprophylaxe | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002238-34 | Sponsor Protocol Number: FFA-MAE-EXT | Start Date*: 2021-03-22 | |||||||||||
Sponsor Name:University Hospital Schleswig-Holstein (UKSH) | |||||||||||||
Full Title: Open label extension study for monitoring long-term safety in patients with Myoclonic Astatic Epilepsy (Doose-Syndrome) receiving Fenfluramine as add-on therapy | |||||||||||||
Medical condition: Childhood epilepsy: Myoclonic Astatic Epilepsy (Doose-Syndrome) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011862-27 | Sponsor Protocol Number: 01-NAB-ZISOP | Start Date*: 2009-09-18 |
Sponsor Name:ZISOP Zentrum für interdisziplinäre Schmerztherapie Landeskrankenhaus Klagenfurt | ||
Full Title: Überprufung der wirksamkeit und Sicherheit einer Add-on Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit Tumorschmerz | ||
Medical condition: Pain related to cancer (solid tumors) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
